Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy

BACKGROUND: Patients with immunodeficiency diseases require lifelong treatment with immunoglobulin (Ig), yet few studies have vetted dosing strategies and effectiveness of Ig in older patient populations. Patients requiring subcutaneous (SC) Ig (SCIG) typically start with intravenous dosing before t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Allergy Asthma Clin Immunol
Hlavní autoři: Koterba, Alan P, Stein, Mark R
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4273447/
https://ncbi.nlm.nih.gov/pubmed/25535489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13223-014-0063-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky